Krka Shareholders to Get Gross Dividends of EUR 4.2
Novo Mesto, 2 July - The Slovene pharmaceutical company Krka is to allocate SIT 3.2bn (EUR 12m) of last year's SIT 20.5bn (EUR 90m) balance sheet profits to dividends, according to a decision made by Krka shareholders who gathered at a general meeting on Wednesday. Gross dividends are to amount to SIT 950 (EUR 4.2), up 36 percent over the previous year, this Novo mesto-based company said.
The rest of this news item is available to subscribers.
The news item consists of 1.249 characters (without spaces) or 248 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.